The association between skin autofluorescence and vascular complications in chinese patients with diabetic foot ulcer: An observational study done in Shanghai

International Journal of Lower Extremity Wounds

Volumn 14, Issue 1, 2015, Pages 28-36

  Liu, Chuanbo ^a   Xu, Liying ^b   Gao, Hui ^c   Ye, Junna ^a   Huang, Yao ^a   Wu, Minjie ^a   Xie, Ting ^a   Ni, Pengwen ^a   Yu, Xiaoping ^a   Cao, Yemin ^b   Lu, Shuliang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

diabetic foot ulcer; skin autofluorescence; vascular complications

Indexed keywords

ADULT; ARTICLE; AUTOFLUORESCENCE; BIOACCUMULATION; CEREBROVASCULAR DISEASE; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SKIN AUTOFLUORESCENCE; SKIN EXAMINATION; UREA NITROGEN BLOOD LEVEL; VASCULAR DISEASE; AGED; CHINA; COMPLICATION; DIABETIC ANGIOPATHIES; FLUORESCENCE; FLUORESCENCE IMAGING; MIDDLE AGED; ODDS RATIO; PATHOLOGY; PROCEDURES; RISK FACTOR; SKIN;

AGED; CHINA; CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; DIABETIC FOOT; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OPTICAL IMAGING; RISK FACTORS; SKIN;

EID: 84927561222     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734614568375     Document Type: Article

References (31)

1. Araszkiewicz A, Naskret D, Niedzwiecki P, Samborski P, Wierusz-Wysocka B, Zozulinska-Ziolkiewicz D. Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes. Diabetes Technol Ther. 2011 ; 13: 837-842
2. Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med. 1998 ; 4: 594-601
3. Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005 ; 83: 876-886
4. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001 ; 44: 129-146
5. Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia. 2004 ; 47: 1324-1330
6. Macsai E, Takats Z, Derzbach L, Korner A, Vasarhelyi B. Verification of skin autofluorescence values by mass spectrometry in adolescents with type 1 diabetes: brief report. Diabetes Technol Ther. 2013 ; 15: 269-272
7. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 ; 359: 1577-1589
8. Genuth S, Sun W, Cleary P, et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes. 2005 ; 54: 3103-3111
9. Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R. Reference values of skin autofluorescence. Diabetes Technol Ther. 2010 ; 12: 399-403
10. Yue X, Hu H, Koetsier M, Graaff R, Han C. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue. Diabet Med. 2011 ; 28: 818-823
11. Simon Klenovics K, Kollarova R, Hodosy J, Celec P, Sebekova K. Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population. Diabet Med. 2014 ; 31: 581-585
12. Samborski P, Naskret D, Araszkiewicz A, Niedzwiecki P, Zozulinska-Ziolkiewicz D, Wierusz-Wysocka B. Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes. Pol Arch Med Wewn. 2011 ; 121: 67-72
13. Tanaka K, Tani Y, Asai J, et al. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with type 2 diabetes. Diabet Med. 2012 ; 29: 492-500
14. Noordzij MJ, Mulder DJ, Oomen PH, et al. Skin autofluorescence and risk of micro- and macrovascular complications in patients with type 2 diabetes mellitus - a multi-centre study. Diabet Med. 2012 ; 29: 1556-1561
15. Hu H, Han CM, Hu XL, Ye WL, Huang WJ, Smit AJ. Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects. J Zhejiang Univ Sci B. 2012 ; 13: 372-377
16. Vouillarmet J, Maucort-Boulch D, Michon P, Thivolet C. Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration. Diabetes Technol Ther. 2013 ; 15: 601-605
17. Meerwaldt R, Lutgers HL, Links TP, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care. 2007 ; 30: 107-112
18. Gerrits EG, Lutgers HL, Kleefstra N, et al. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care. 2008 ; 31: 517-521
19. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010 ; 362: 1090-1101
20. Martinez-De Jesus FR. A checklist system to score healing progress of diabetic foot ulcers. Int J Low Extrem Wounds. 2010 ; 9: 74-83
21. Bakker K, Apelqvist J, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012 ; 28: 225-231
22. Ishino Y, Yokoi N, Yasuhara T, et al. Investigation of corneal autofluorescence in diabetic patients. Jpn J Ophthalmol. 2001 ; 45 (1). 116
23. Lipsky BA, Peters EJG, Senneville E, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012 ; 28: 163-178
24. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care. 1999 ; 22: 1036-1042
25. Lepäntalo M, Apelqvist J, Setacci C, et al. Chapter V: Diabetic foot. Eur J Vasc Endovasc Surg. 2011 ; 42: S60 - S74
26. Tendera M, Aboyans V, Bartelink ML, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011 ; 32: 2851-2906
27. Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Vasc Surg. 2011 ; 54 (5). e32 - e58
28. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2000 ; 16: S84 - S92
29. Gerrits EG, Lutgers HL, Kleefstra N, et al. Skin advanced glycation end product accumulation is poorly reflected by glycemic control in type 2 diabetic patients (ZODIAC-9). J Diabetes Sci Technol. 2008 ; 2: 572-577
30. Genevieve M, Vivot A, Gonzalez C, et al. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus. Diabetes Metab. 2013 ; 39: 349-354
31. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006 ; 295: 1681-1687